News & Updates
Filter by Specialty:
Biomarker-driven therapies superior to standard care in breast cancer
Patients with breast cancer may gain greater therapeutic advantages from biomarker-driven than standard-of-care therapies, suggests a study.
Biomarker-driven therapies superior to standard care in breast cancer
02 Nov 2023
Esketamine outperforms quetiapine in head-to-head depression trial
In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.
Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023
Antiviral therapy safe, effective in children with immune-tolerant HBV infection
Treatment with antiviral therapy is beneficial and generally tolerated in children with chronic hepatitis B virus (HBV) infection in the immune-tolerant stage, according to the results of a systematic review and meta-analysis.
Antiviral therapy safe, effective in children with immune-tolerant HBV infection
28 Oct 2023
Canagliflozin holds promise against MAFLD in T2D patients
Patients with type 2 diabetes (T2D) who received canagliflozin benefit from improved liver biochemistry and metabolism, a recent study has shown. In addition, treatment with canagliflozin appears to confer positive effects on liver fibrosis.
Canagliflozin holds promise against MAFLD in T2D patients
27 Oct 2023
Ivarmacitinib efficacious, well tolerated in moderate-to-severe alopecia areata
Use of ivarmacitinib 4- and 8-mg doses for 24 weeks eases hair loss and is generally tolerated in patients with moderate or severe alopecia areata (AA), a phase II study has shown.